Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone Added to Lidocaine for IANB in Irreversible Pulpitis
NCT05361291Completed
- Sponsor
- Jamia Millia Islamia
- Start
- Feb 2020
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexamethasone in irreversible pulpitis (3 arms), sponsored by Jamia Millia Islamia. Primary endpoint: Anesthetic success rate. Started Feb 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT05361291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05361291.